Aphios Company
Aphios enhances therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders such as Alzheimer’s Disease; Targeted Nanoparticles for Orphan and Chronic Diseases
Technology:
Others
Industry:
Risk Mitigation
Headquarters:
USA
Founded Date:
1993
Employees Number:
11-50
Total Funding:
$2.40
Estimated Revenue:
$1M to $10M
Register and Claim Ownership